Connect with us

Hi, what are you looking for?

Global Liraglutide Market Size 2022 Manufacturers, Regions, Share, Key Players, Analysis, Type, Application, Dynamics and Forecast to 2026

Liraglutide Market 2022 offers company details, business overview and its total revenue, CAGR Status, PEST analysis, product scope, top countries, including top manufacturers

Global “Liraglutide Market” research report provides the market potential for each geographical region based on the growth factor, revenue, market demand, dynamics and supply scenarios. Liraglutide Market report includes analysis with market forecast, types, applications, major manufacturers, opportunities, industry challenges, development factors, suppliers, consumption.

Get a Sample Copy of the Report – http://www.industryresearch.co/enquiry/request-sample/15063937

About Liraglutide Market:

Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenous metabolic hormone GLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment for obesity in adults with at least one weight-related comorbid condition.
The total amount of Patents about Liraglutide are 1871, among those Patents, 44%is about application, 26%is about Combination therapy, and 12%is about Preparation method.
In these patents, accounting for Europe is the largest, followed by North America, and finally Asia.
The application of Liraglutide
Liraglutide for the treatment of type 2 diabetes mellitus
Liraglutide 1.2 mg daily in triple therapy regimens (in combination with metformin and a sulphonylurea, or metformin and a thiazolidinedione) is recommended as an option for the treatment of people with type 2 diabetes, only if used as described for exenatide in ‘Type 2 diabetes: the management of type 2 diabetes’
Liraglutide 1.2 mg daily in dual therapy regimens (in combination with metformin or a sulphonylurea) is recommended as an option for the treatment of people with type 2 diabetes, only if the person is intolerant of either metformin or a sulphonylurea, or treatment with metformin or a sulphonylurea is contraindicated, and the person is intolerant of thiazolidinediones and dipeptidyl peptidase-4 (DPP-4) inhibitors, or treatment with thiazolidinediones and DPP-4 inhibitors is contraindicated.
Liraglutide 1.8 mg daily is not recommended for the treatment of people with type 2 diabetes.
The Committee concluded that the evidence provided was not robust enough to allow it to recommend liraglutide as a cost-effective alternative to either thiazolidinediones or DPP-4 inhibitors as a triple therapy regimen, however it believes liraglutide is a cost-effective treatment option relative to exenatide.
Taking into account the lack of clinical trial evidence showing a significant benefit from increasing the liraglutide dose from 1.2 mg to 1.8 mg, the widely varying ICERs and the uncertainty in the economic analysis, the Committee was unable to recommend liraglutide 1.8 mg for the treatment of type 2 diabetes.
The Committee concluded that people with type 2 diabetes currently receiving liraglutide who do not meet the criteria specified in section 1.1 or 1.3, or who are receiving liraglutide 1.8 mg, should have the option to continue their current treatment until they and their clinicians consider it appropriate to stop.

The global Liraglutide market is valued at million USD in 2020 is expected to reach million USD by the end of 2026, growing at a CAGR

List of Top Key Players in Liraglutide Market Report Are: –

  • HEC Pharm
  • Bachem
  • Bharat Pharmaceuticals
  • Kingpep Biotechnology
  • Shenzhen JYMed Technology
  • Wuxi Asiapeptide
  • AmbioPharm

This report focuses on the global Liraglutide status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Liraglutide development in North America, Europe, China, Japan, Southeast Asia, India and Central and South America.

For More Information or Query or Customization Before Buying, Visit at http://www.industryresearch.co/enquiry/pre-order-enquiry/15063937

Liraglutide market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020.

Liraglutide Market segment by Type, the product can be split into

  • Pills
  • Liquid

Liraglutide Market segment by Application, split into

  • Hospital
  • Drug Store

Liraglutide Market report provides comprehensive analysis of

  • Key market segments and sub-segments
  • Evolving market trends and dynamics
  • Changing supply and demand scenarios
  • Quantifying Liraglutide market opportunities through market sizing and market forecasting
  • Tracking current trends/opportunities/challenges
  • Competitive insights
  • Opportunity mapping in terms of technological breakthroughs

Get a Sample Copy of the Report – http://www.industryresearch.co/enquiry/request-sample/15063937

Some of the Key Questions Answered in this Report:

  • Liraglutide market report provides comprehensive analysis of the market with the help of up-to-date market opportunities, overview, outlook, challenges, trends, market dynamics, size and growth, competitive analysis, major competitors analysis.
  • Report recognizes the key drivers of growth and challenges of the key industry players. Also, evaluates the future impact of the propellants and limits on the market.
  • Uncovers potential demands in the Liraglutide market.
  • Liraglutide market report provides in-depth analysis for changing competitive dynamics
  • Provides information on the historical and current market size and the future potential of the market.

Geographical Regions covered in Liraglutide market report are:

  • North America (U.S. and Canada) Market size, Y-O-Y growth, Market Players Analysis and Opportunity Outlook
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth and Market Players Analysis and Opportunity Outlook
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands and Luxembourg, NORDIC (Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y Growth Market Players Analyse and Opportunity Outlook
  • Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth and Market Players Analysis and Opportunity Outlook

Purchase this Report (Price 2900 USD for a Single-User License) – http://www.industryresearch.co/purchase/15063937

Liraglutide Market TOC Covers the Following Points:

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered: Ranking by Liraglutide Revenue

1.4 Market Analysis by Type

1.4.1 Global Liraglutide Market Size Growth Rate by Type: 2020 VS 2026

1.5 Market by Application

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends by Regions

2.1 Market Perspective (2015-2026)

2.2 Growth Trends by Regions

2.2.1 Market Size by Regions: 2015 VS 2020 VS 2026

2.2.2 Historic Market Share by Regions (2015-2020)

2.2.3 Forecasted Market Size by Regions (2021-2026)

2.3 Industry Trends and Growth Strategy

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Challenges

2.3.4 Porter’s Five Forces Analysis

2.3.5 Liraglutide Market Growth Strategy

2.3.6 Primary Interviews with Key Liraglutide Players (Opinion Leaders)

3 Competition Landscape by Key Players

3.1 Global Top Players by Market Size

3.1.1 Global Top Players by Revenue (2015-2020)

3.1.2 Global Revenue Market Share by Players (2015-2020)

3.1.3 Global Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

3.2 Global Market Concentration Ratio

3.2.1 Global Market Concentration Ratio (CR5 and HHI)

3.2.2 Global Top 10 and Top 5 Companies by Liraglutide Revenue in 2019

3.3 Liraglutide Key Players Head office and Area Served

3.4 Key Players Liraglutide Product Solution and Service

3.5 Date of Enter into Liraglutide Market

3.6 Mergers and Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

4.1 Global Historic Market Size by Type (2015-2020)

4.2 Global Forecasted Market Size by Type (2021-2026)

5 Liraglutide Breakdown Data by Application (2015-2026)

5.1 Global Market Size by Application (2015-2020)

5.2 Global Forecasted Market Size by Application (2021-2026)

6 North America

6.1 North America Market Size (2015-2020)

6.2 Key Players in North America (2019-2020)

6.3 North America Market Size by Type (2015-2020)

6.4 North America Market Size by Application (2015-2020)

7 Europe

7.1 Europe Market Size (2015-2020)

7.2 Liraglutide Key Players in Europe (2019-2020)

7.3 Europe Market Size by Type (2015-2020)

7.4 Europe Market Size by Application (2015-2020)

8 China

8.1 China Market Size (2015-2020)

8.2 Key Players in China (2019-2020)

8.3 China Market Size by Type (2015-2020)

8.4 China Market Size by Application (2015-2020)

9 Japan

9.1 Japan Market Size (2015-2020)

9.2 Key Players in Japan (2019-2020)

9.3 Japan Market Size by Type (2015-2020)

9.4 Japan Market Size by Application (2015-2020)

10 Southeast Asia

10.1 Southeast Asia Market Size (2015-2020)

10.2 Key Players in Southeast Asia (2019-2020)

10.3 Southeast Asia Market Size by Type (2015-2020)

10.4 Southeast Asia Market Size by Application (2015-2020)

11 India

11.1 India Market Size (2015-2020)

11.2 Key Players in India (2019-2020)

11.3 India Market Size by Type (2015-2020)

11.4 India Market Size by Application (2015-2020)

12 Central and South America

12.1 Central and South America Market Size (2015-2020)

12.2 Key Players in Central and South America (2019-2020)

12.3 Central and South America Market Size by Type (2015-2020)

12.4 Central and South America Market Size by Application (2015-2020)

13 Key Players Profiles

14 Analyst’s Viewpoints/Conclusions

15Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Disclaimer

15.3 Author Details

Contact Us:

Industry Research Co

Phone: US +1 424 253 0807

UK +44 203 239 8187

Email: sales@industryresearch.co

Web: https://www.industryresearch.co

Press Release Distributed by The Express Wire

To view the original version on The Express Wire visit Global Liraglutide Market Size 2022 Manufacturers, Regions, Share, Key Players, Analysis, Type, Application, Dynamics and Forecast to 2026

Written By

You may also like:

Entertainment

Emmy-nominated actor Justin Hartley is chasing ghosts in the new episode titled "Aurora" on '"Tracker" on CBS.

Business

The electric car maker, which enjoyed scorching growth for most of 2022 and 2023, has experienced setbacks.

Business

A calendar marking the days day trippers have to pay entry fees - Copyright AFP GABRIEL BOUYSGildas LE ROUXVenice will this week begin charging...

World

The UK risks a major showdown with the Council of Europe - Copyright AFP Sam YehEurope’s highest rights body on Tuesday called on Britain...